GlaxoSmithKline and Vir aim to take on Covid-19 with antibodies and CRISPR
The drug giant GlaxoSmithKline said Monday it will collaborate with Vir Biotechnology on experimental treatments and potentially, vaccines against the novel coronavirus. As part of …